A Randomized Controlled Trial of Everolimus-eluting Stents and Paclitaxel-eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 19 Nov 2015

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Everolimus (Primary) ; Paclitaxel
Indications Acute coronary syndromes; Angina pectoris; Coronary artery disease; Coronary artery restenosis; Unstable angina pectoris
Focus Therapeutic Use
Acronyms COMPARE; COMPARE 1

05 Apr 2011 Pooled analysis results presented at the 60th Annual Scientific Session of the American College of Cardiology.
05 Apr 2011 Two-year results of a patient-level pooled analysis of the SPIRIT II, III, IV and COMPARE trials presented at the 60th Annual Scientific Session of the American College of Cardiology.
21 Sep 2010 Results of 2-year follow-up were presented in an abstract at the Cardiovascular Research Foundation's 22nd annual Transcatheter Cardiovascular Therapeutics conference.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com